首页 | 本学科首页   官方微博 | 高级检索  
     


Cytotoxic and Genotoxic Effects of cis-Tetraammine(oxalato)Ruthenium(III) Dithionate on the Root Meristem Cells of Allium cepa
Authors:Flávia de Castro Pereira  Cesar Augusto Sam Tiago Vilanova-Costa  Aliny Pereira de Lima  Alessandra de Santana Braga Barbosa Ribeiro  Hugo Delleon da Silva  Luiz Alfredo Pavanin  Elisângela de Paula Silveira-Lacerda
Affiliation:(1) Laboratório de Genética Molecular e Citogenética, Instituto de Ciências Biológicas–ICB I–Sala 200, Universidade Federal de Goiás, Campus Samambaia (Campus II), Cx. Postal: 2425-0, Goiania, GO, 74690-970, Brazil;(2) Instituto de Química, Universidade Federal de Uberlandia–UFU, Uberlandia, Minas Gerais, Brazil
Abstract:Ruthenium complexes have attracted much attention as possible building blocks for new transition-metal-based antitumor agents. The present study examines the mitotoxic and clastogenic effects induced in the root tips of Allium cepa by cis-tetraammine(oxalato)ruthenium(III) dithionate {cis-[Ru(C2O2)(NH3)4]2(S2O6)} at different exposure durations and concentrations. Correlation tests were performed to determine the effects of the time of exposure and concentration of ruthenium complex on mitotic index (MI) and mitotic aberration index. A comparison of MI results of cis-[Ru(C2O2)(NH3)4]2(S2O6) to those of lead nitrate reveals that the ruthenium complex demonstrates an average mitotic inhibition eightfold higher than lead, with the frequency of cellular abnormalities almost fourfold lower and mitotic aberration threefold lower. A. cepa root cells exposed to a range of ruthenium complex concentrations did not display significant clastogenic effects. Cis-tetraammine(oxalato)ruthenium(III) dithionate therefore exhibits a remarkable capacity to inhibit mitosis, perhaps by inhibiting DNA synthesis or blocking the cell cycle in the G2 phase. Further investigation of the mechanisms of action of this ruthenium complex will be important to define its clinical potential and to contribute to a novel and rational approach to developing a new metal-based drug with antitumor properties complementary to those exhibited by the drugs already in clinical use.
Keywords:Cis-tetraammine(oxalato)ruthenium(III) dithionate  Cytotoxicity  Genotoxicity   Allium cepa   Ruthenium compounds
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号